“Dr. Schwartz and his staff are friendly, professional, and efficient. Highly recommend for excellent eye care.”
Subretinal Fluid in AMD: What You Need to Know
Who Is at Risk for AMD and Subretinal Fluid
AMD is one of the most common causes of vision loss in older adults. Several factors influence who develops the condition and who is most likely to progress to the wet form with subretinal fluid.
Age is the strongest risk factor for AMD. Risk begins to rise around age 40 and increases significantly after age 75. If a parent, sibling, or child has been diagnosed with macular degeneration, your own risk is higher. Genetics play a meaningful role in who develops AMD.
Several modifiable factors are associated with a higher risk of developing or worsening AMD.
- Smoking doubles the risk of AMD.
- A diet high in saturated fat and low in antioxidants can increase risk.
- Uncontrolled cardiovascular disease or high blood pressure is associated with higher AMD risk.
- Being overweight is linked to a greater likelihood of developing AMD.
Addressing these factors does not guarantee prevention, but it may support overall eye health and reduce the risk of progression.
Not everyone with AMD will develop subretinal fluid. Subretinal fluid is a hallmark of wet AMD, which is the less common but more severe form of the disease. Dry AMD can progress to wet AMD at any point, which is why ongoing monitoring is essential even for patients who currently have only the dry form.
Recognizing the Symptoms
Symptoms of AMD and subretinal fluid can range from subtle and gradual to sudden and alarming. Knowing what to look for helps you act quickly when it matters most.
In the intermediate stages of dry AMD, you may notice difficulty reading in dim light, a decrease in the brightness or intensity of colors, or mild distortion of straight lines. These changes often develop slowly over months or years and can be easy to overlook at first.
When wet AMD develops and subretinal fluid accumulates, symptoms can appear more suddenly. Common signs include marked distortion of straight lines, blurry or dark areas in the center of your visual field, difficulty reading or recognizing faces, and trouble driving, particularly at night.
A sudden change in your central vision, such as new dark spots, sudden blurriness, or straight lines appearing wavy or bent, may mean wet AMD has developed or progressed. Contact a retina specialist or go to an emergency room immediately if this happens. Early evaluation can make a meaningful difference in outcomes.
When fluid collects beneath the macula, it physically lifts the retina away from its normal position. This displacement distorts the images sent to the brain. Faces may appear blurry, text may look wavy, and colors may seem washed out. The degree of visual impact depends on how much fluid is present and where it sits relative to the center of the macula.
How Subretinal Fluid Is Diagnosed
Accurate diagnosis of subretinal fluid depends on specialized imaging that reveals the structure of the retina in fine detail. Our team uses several tools to detect fluid, measure its extent, and track changes over time.
Optical coherence tomography, commonly called OCT, is the primary tool for detecting subretinal fluid. This noninvasive test uses light waves to create detailed cross-sectional images of the retinal layers. On an OCT scan, subretinal fluid appears as a dark pocket between the retina and the RPE. Your retina specialist uses OCT at nearly every visit to measure the amount of fluid and monitor how it changes with treatment.
Fluorescein angiography involves injecting a harmless dye into a vein in your arm and then photographing the retina as the dye travels through the blood vessels. Areas where abnormal vessels are leaking show up clearly in these images. This test helps your retina specialist identify exactly where the problem vessels are located, which guides treatment decisions.
OCT angiography, or OCTA, is an imaging method that maps the blood vessels of the retina without a dye injection. It shows blood flow in different retinal layers and can reveal the abnormal vessel networks associated with wet AMD. While it does not replace standard angiography in every situation, it provides a quick and comfortable way to monitor vascular changes between treatments.
Your retina specialist may recommend at-home monitoring tools between office visits. The Amsler grid is a simple chart with a central dot and a grid of lines. Holding it at reading distance and covering one eye, you check for new waviness, missing areas, or distortion. Any change should prompt a prompt call to your retina specialist, as catching shifts early allows for timely treatment adjustments.
Treatment Options for Subretinal Fluid
The treatment for subretinal fluid caused by wet AMD has advanced considerably and continues to evolve. The goal is to reduce fluid, stabilize vision, and minimize the burden of ongoing care as much as possible.
Anti-VEGF therapy is the standard treatment for subretinal fluid in wet AMD. Vascular endothelial growth factor (VEGF) is a protein that drives the growth of abnormal blood vessels and promotes fluid leakage. Anti-VEGF medications block this protein, helping to reduce fluid and stabilize or improve vision.
These medications are delivered as intravitreal injections, meaning they are placed directly into the vitreous cavity of the eye. Treatment typically begins with a series of loading doses given every four weeks, then transitions to an individualized schedule based on how your eye responds.
Several anti-VEGF agents are available for treating subretinal fluid in wet AMD. Your retina specialist will select the medication and schedule that best fits your situation.
- Eylea (aflibercept) is one of the most commonly used agents, typically given every 4 to 8 weeks after initial loading doses.
- Lucentis (ranibizumab) was the first anti-VEGF medication approved for use in the eye and is typically given every 4 weeks.
- Avastin (bevacizumab) is used off-label for eye conditions and is typically given every 4 to 6 weeks.
- Vabysmo (faricimab) targets both VEGF and a second protein called angiopoietin-2, with dosing intervals that can extend to every 16 weeks.
- Eylea HD (high-dose aflibercept) allows dosing intervals up to every 20 weeks for qualifying patients who have responded well after one year of treatment.
Many patients see a meaningful reduction in subretinal fluid with anti-VEGF therapy. Clinical data show that while most eyes respond to treatment, some patients experience fluid that persists despite regular injections. In those cases, your retina specialist may adjust the medication, dosing frequency, or treatment approach to find what works best for your eye.
Wet AMD is a chronic condition. Most patients require ongoing treatment to keep subretinal fluid controlled and vision as stable as possible. Staying consistent with your treatment schedule is one of the most important things you can do to protect your sight.
Researchers continue to develop treatments designed to reduce the frequency of injections while maintaining strong fluid control. The port delivery system with ranibizumab (Susvimo) is a surgically implanted, refillable device that continuously delivers medication into the eye and is FDA-approved for wet AMD. Gene therapy approaches are also in clinical study, with early results suggesting they may significantly reduce the number of supplemental injections needed. These developments point toward a future where wet AMD management may involve fewer visits without sacrificing effectiveness.
Subretinal fluid is primarily a feature of wet AMD. However, patients with dry AMD should know that a treatment called Izervay (avacincaptad pegol), a complement inhibitor that slows the progression of geographic atrophy (the advanced form of dry AMD), is FDA-approved. Geographic atrophy is a form of late-stage dry AMD where areas of the retina gradually deteriorate. This medication is not used for wet AMD or subretinal fluid, but it represents meaningful progress for patients at risk of advancing dry AMD.
Living With AMD and Subretinal Fluid
Managing wet AMD is an ongoing process that extends beyond office visits. Daily habits, lifestyle choices, and emotional support all play a role in living well with this condition.
Consistency is one of the most important factors in managing subretinal fluid. Skipping or delaying injections can allow fluid to return and cause further damage to the macula. Patients who maintain their treatment schedules tend to have better long-term visual outcomes. If scheduling or travel is a barrier, talk to your retina specialist about options that may work better for your routine.
While treatment targets the disease directly, certain lifestyle choices support overall eye health. Quitting smoking is one of the most impactful steps a person with AMD can take. Eating a diet rich in leafy greens, colorful fruits and vegetables, and fish may also be beneficial.
- Quit smoking if you currently smoke.
- Eat a diet rich in leafy greens, colorful fruits, and fish.
- Manage blood pressure and cardiovascular health.
- Maintain a healthy weight.
- Wear sunglasses that block ultraviolet light when outdoors.
Your retina specialist may also recommend nutritional supplements based on the AREDS2 formula, depending on your stage of AMD. These supplements have been shown to reduce the risk of progression to advanced AMD in certain patients.
Living with a chronic eye condition can be stressful, and it is completely normal to feel anxious about vision changes or the need for repeated injections. Low vision rehabilitation services can help you make the most of your remaining vision. Support groups, both in person and online, connect you with others who understand the challenges of living with AMD. Do not hesitate to speak openly with your retina specialist about concerns beyond the medical side of your care.
When to See a Retina Specialist
Knowing when to seek care, and how urgently, can make a real difference in protecting your vision. Some situations require a same-day call or visit, while others call for scheduled monitoring.
Go to the emergency room or contact a retina specialist immediately if you experience any of the following.
- A sudden increase in floaters, which are the small dark spots, specks, or lines that drift through your vision.
- Flashes of light, especially in your side vision.
- A dark curtain or shadow spreading across your field of vision.
- Sudden vision loss in one eye.
- Sudden new distortion where straight lines appear bent or wavy.
These symptoms can signal a retinal tear, detachment, or a sudden worsening of wet AMD. Prompt care is critical.
If you have been diagnosed with any form of AMD, regular visits with a retina specialist are essential. Subretinal fluid can develop without obvious symptoms, and OCT imaging can detect it before significant vision loss occurs. Your retina specialist will determine the monitoring schedule that is right for your specific stage and situation.
Dry AMD can convert to wet AMD at any time. If you have been diagnosed with dry AMD, stay alert for new or sudden symptoms such as distortion of straight lines, blurriness, or dark spots in your central vision. Report any changes to your retina specialist right away. Treating wet AMD early, before extensive fluid and scarring develop, leads to better outcomes than delayed care.
Frequently Asked Questions
These answers address common questions patients ask about subretinal fluid, adding practical guidance beyond what is covered in the sections above.
Many patients see significant fluid reduction with anti-VEGF therapy, and for some, fluid resolves entirely. However, a meaningful portion of patients have fluid that persists even with regular treatment. Persistent fluid does not automatically mean treatment has failed. Small amounts of stable fluid can sometimes coexist with well-preserved vision. Your retina specialist evaluates the amount, location, and trend of fluid over time before deciding whether a change in medication or schedule is needed.
No. Subretinal fluid collects beneath the retina, between the sensory retina and the RPE. Intraretinal fluid accumulates within the layers of the retina itself and often appears as small cysts on OCT imaging. Both are signs of active wet AMD, but they can behave differently and respond differently to treatment. Your retina specialist monitors both types when making decisions about your care.
Wet AMD is a chronic condition, and most patients do require ongoing treatment to keep subretinal fluid controlled. That said, treatment frequency varies from person to person. Some patients are able to extend the time between injections as their condition stabilizes, while others need more consistent care. Newer medications and sustained-delivery devices are reducing the treatment burden for many patients. Your retina specialist will work with you to find a schedule that balances effectiveness with practicality.
Yes. Using an Amsler grid at home is one of the most practical steps. Check it regularly by holding it at reading distance, covering one eye, and looking at the central dot. If the grid lines appear wavy, bent, or missing, contact your retina specialist promptly rather than waiting for your next scheduled visit. Maintaining your injection schedule, following lifestyle recommendations, and reporting any new symptoms quickly are also important ways to protect your vision between appointments.
There is no guaranteed way to prevent dry AMD from converting to wet AMD. However, managing modifiable risk factors such as smoking, diet, blood pressure, and weight is associated with lower overall AMD risk. For patients with intermediate dry AMD, AREDS2 nutritional supplements have been shown to reduce the risk of progressing to advanced AMD in certain individuals. Regular monitoring with a retina specialist is the most effective way to catch any conversion to wet AMD as early as possible, when treatment is most effective.
Bring a list of your current medications, including any supplements, along with the names and contact information for your referring eye doctor or primary care provider. If you have had previous eye imaging performed elsewhere, bringing those records or asking for them to be sent in advance can help your retina specialist understand your history from the start. Arriving with a support person is also a good idea, particularly for a first visit, since you may receive dilating eye drops that temporarily blur your vision and make driving difficult.
Visit Atlantic Retina Center
At Atlantic Retina Center, our team is dedicated exclusively to the retina, vitreous, and macula, bringing focused expertise to every patient we see across the Eastern Shore of Maryland and central and southern Delaware. If you have been diagnosed with AMD, are experiencing new vision changes, or have been referred for a retinal evaluation, we are here to help. Our fellowship-trained retina specialists use advanced imaging and the full range of proven treatments to protect your vision and support you every step of the way. We look forward to caring for you.